Related Experiment Video

Updated: Jun 22, 2026

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs
04:15

A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs

Published on: February 2, 2024

Function and antagonism of beta3 integrins in the development of cancer therapy

H M Sheldrake1, L H Patterson

  • 1Institute of Cancer Therapeutics, University of Bradford, Bradford, BD7 1DP, UK. h.sheldrake@bradford.ac.uk

Current Cancer Drug Targets
|June 13, 2009
PubMed

Insights

Beta-3 integrins are crucial cell receptors involved in cancer cell migration and survival. Small molecule antagonists targeting these integrins show promise for developing new anti-cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Integrins are cell surface receptors mediating cell-extracellular matrix interactions, crucial for cell adhesion, migration, proliferation, and survival.
  • Altered integrin expression in cancer cells promotes malignant cell interactions with the extracellular matrix, enhancing migration and survival.
  • Beta-3 integrins play a significant role in cancer metastasis, with specific integrin subtypes (alpha(IIb)beta(3) and alpha(n)beta(3)) linked to metastatic potential.

Purpose of the Study:

  • To review the role of beta-3 integrins in normal and tumor tissues.
  • To discuss the development of small-molecule antagonists targeting beta-3 integrins.
  • To explore the potential anti-cancer applications of these antagonists.

Main Methods:

  • Review of existing literature on beta-3 integrin function in normal and cancer cells.
  • Analysis of the development of small molecule beta-3 integrin antagonists, from linear peptides to peptidomimetics.
  • Examination of preclinical and clinical data on the anti-cancer potential of these antagonists.

Main Results:

  • Beta-3 integrins are implicated in all stages of cancer metastasis.
  • The RGD binding motif has been key in designing beta-3 integrin antagonists.
  • Small molecule peptidomimetics offer improved pharmacological properties over earlier peptide-based antagonists.

Conclusions:

  • Beta-3 integrins are critical regulators of cancer cell behavior and metastasis.
  • Targeting beta-3 integrins with small molecule antagonists represents a promising therapeutic strategy for cancer.
  • Further development and application of these antagonists hold potential for improved cancer treatment outcomes.

More Related Videos

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies06:27

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies

Published on: August 8, 2019

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...